Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Harvard Business School
Moodys
Citi
US Army
Teva
Medtronic
Colorcon
Argus Health

Generated: May 27, 2018

DrugPatentWatch Database Preview

MESNEX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Mesnex, and what generic alternatives are available?

Mesnex is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in MESNEX is mesna. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mesna profile page.
Drug patent expirations by year for MESNEX
Pharmacology for MESNEX
Medical Subject Heading (MeSH) Categories for MESNEX
Synonyms for MESNEX
19767-45-4
2-Mercapto-ethan-sulfonsaeure, natrium-salz
2-mercaptoethane sulfonate
2-Mercaptoethane sulfonate sodium
2-MERCAPTOETHANE SULFONIC ACID
2-mercaptoethane sulfonic acid sodium salt
2-Mercaptoethanesulfonate, sodium
2-Mercaptoethanesulfonic acid monosodium salt
2-mercaptoethanesulfonic acid sodium
2-Mercaptoethanesulfonic acid sodium salt
2-Mercaptoethanesulfonic,Mesna
2-mercaptoethanesulphonic acid sodium salt
2-UI>>uOO>>CEa AAENI
3375-50-6 (parent cpd)
A M AAENI
A8469
AB0013231
AB01274734-01
AB2000259
AC-6011
AC1Q1VK3
AC1Q1VK4
ACMC-209f1l
AK163673
AKOS006220661
AKOS015960755
ANW-23767
AS-13260
ASTA-D 7093
BB_SC-5473
BC204054
C2H5NaO3S2
CAS-19767-45-4
CCG-40134
CCRIS 3712
CHEBI:31824
CHEMBL975
coenzyme M
Coenzyme M sodium salt
CPD000059219
CS-1364
CTK4E2249
D 7093
D-7093
D01459
D0C3YQ
DSSTox_CID_809
DSSTox_GSID_20809
DSSTox_RID_75800
DTXSID1020809
EBD6310
EINECS 243-285-9
EN300-49858
Ethanesulfonic acid, 2-mercapto-, monosodium salt
H751
HMS1921D10
HMS2092N09
HMS2236L05
HMS3259D13
HMS3372M11
HMS3655M06
HMS502F17
HS-CoM Na
HY-13679
I09-0289
KB-274297
KBio3_002565
KBioGR_000501
KS-00000V6Q
KSC542E4T
LS-7484
M-2956
M0913
mercaptoethanesulfonic acid sodium salt
mesna
Mesna (JAN/USAN/INN)
Mesna (Uromitexan, Mesnex)
Mesna [USAN:BAN:INN]
Mesna [USAN:USP:INN:BAN]
Mesna, coenzyme M
Mesna, Shionogi
Mesnex (TN)
Mesnum
Mesnum [INN-Latin]
Mexan
MFCD00007535
Mistabron
Mistabronco
Mitexan
MLS001074691
MLS001333251
MLS001333252
MolPort-003-666-395
Mucofluid
Natrium 2-mercaptoethansulfonat
NC00648
NCGC00094939-01
NCGC00094939-02
NCGC00178318-04
NCGC00181166-01
NCGC00258417-01
NR7O1405Q9
NSC 113891
OR021914
potassium 2-sulfanylethanesulfonate
Prestwick_1005
Q-201713
RTR-036066
s1735
SAM002548937
SC-18811
SCHEMBL7993
SMR000059219
Sodium 2-mercaptoethane sulfonate
sodium 2-mercaptoethane-1-sulfonate
Sodium 2-mercaptoethanesulfonate
Sodium 2-mercaptoethanesulfonate; Mesnaum; Mesnex
Sodium 2-Mercaptoethanesulphonate
sodium 2-sulfanylethane-1-sulfonate
sodium, 2-mercapto-ethanesulfonate
sodium;2-sulfanylethanesulfonate
SPBio_000764
SPECTRUM1502014
Spectrum2_000752
Spectrum3_001483
Spectrum4_000041
Spectrum5_001174
ST24049216
Tox21_112767
Tox21_112767_1
Tox21_200863
TR-036066
UCB-3983
UNII-NR7O1405Q9
Uromitexan
Uromitexan (TN)
Uromitexan;Mesnex
W-60283
XOGTZOOQQBDUSI-UHFFFAOYSA-M
Z1741968275

US Patents and Regulatory Information for MESNEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for MESNEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare MESNEX mesna TABLET;ORAL 020855-001 Mar 21, 2002 ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare MESNEX mesna INJECTABLE;INTRAVENOUS 019884-001 Dec 30, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Cantor Fitzgerald
UBS
Chinese Patent Office
Merck
Express Scripts
Fish and Richardson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.